- Company Directors - G
- Gallagher Michael R
Insider Trading History of Gallagher Michael R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gallagher Michael R since 2011.
The trader's CIK number is 1158587.
At the time of the last reporting, Gallagher Michael R was the Director of Allergan Plc. (stock ticker symbol AGN).
Also see all insider trading activities at Allergan Plc.
Note that in the past
GALLAGHER MICHAEL R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allergan Plc (AGN) by Gallagher Michael R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | AGN | 0 | $0 | 0 | $0 | 17,693 | $4,339,208 |
Yearly summary of insider trading at Allergan Inc (AGN) by Gallagher Michael R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | AGN | 0 | $0 | 50,500 | $4,635,347 | 30,400 | $1,367,891 |
2011 | AGN | 0 | $0 | 5,000 | $377,710 | 5,000 | $184,250 |
Insider trading activities at 2 companies by Gallagher Michael R:
1. Allergan Plc (AGN)
2. Allergan Inc (AGN)
Table 1. Insider trading of Allergan Plc (AGN) by Gallagher Michael R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-05-04 | AGN | Option Ex | 17,693 | 245.25 | 4,339,208 |
Table 2. Insider trading of Allergan Inc (AGN) by Gallagher Michael R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-11-28 | AGN | Option Ex | 9,768 | 49.19 | 480,468 |
2012-11-26 | AGN | Sale | 4,700 | 91.20 | 428,658 |
2012-11-27 | AGN | Option Ex | 20,632 | 43.01 | 887,423 |
2012-11-28 | AGN | Sale | 13,366 | 91.48 | 1,222,761 |
2012-11-27 | AGN | Sale | 32,434 | 92.00 | 2,983,928 |
2011-02-17 | AGN | Sale | 5,000 | 75.54 | 377,710 |
2011-02-17 | AGN | Option Ex | 5,000 | 36.85 | 184,250 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gallagher Michael R
(Director of Allergan Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.